SLU-PP-332 (5 mg Vial)

SLU-PP-332 (5 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.

Designed for biological research and industrial applications, not intended for individual clinical or medical purposes.
SLU-PP-332 (5 mg Vial)

Synonyms/Alias: SLU-PP-332

Purity: Specification by inquiry

Custom Peptide Support

  • Sequence, purity and scale confirmation
  • CoA and technical documentation requests
  • API, research and cosmetic peptide options
  • Distributor and institution quotation support

SLU-PP-332 (5 mg Vial): reconstitution reference for research laboratories. Includes the diluent volume and resulting concentration, syringe-unit conversion, vial and consumable planning, and storage guidance.

Quickstart

Evidence Base: Preclinical onlyβ€”in vivo mouse studies with intraperitoneal dosing (25–50 mg/kg twice daily).

Reconstitute: Add 3.0 mL bacteriostatic water β†’ ~ 1.67 mg/mL concentration.

Murine dose range: 1250–2500 mcg daily (for a 25 g mouse), administered in two divided doses.

Easy measuring: At 1.67 mg/mL, 1 unit = 0.01 mL β‰ˆ 16.7 mcg on a U-100 insulin syringe.

Storage: Lyophilized: βˆ’20 Β°C (βˆ’4 Β°F); reconstituted: 2–8 Β°C (35.6–46.4 Β°F).

Notes

Research compound considerations. No human data: SLU-PP-332 has not been tested in human subjects; all evidence is from murine models. Use new sterile syringes for each administration; dispose in a sharps container. Rotate injection sites to reduce local irritation. Document administration times, doses, and any observations. This compound is for research purposes onlyβ€”not for human consumption.

Single peptide protocol reference: Available for related research, development or formulation inquiry workflows.

Reconstitution and handling reference: Available for related research, development or formulation inquiry workflows.

Research-use documentation inquiry: Available for related research, development or formulation inquiry workflows.

Weeks 1–2
Daily Dose (mcg): 1250 mcg | Per-Injection Dose (mcg): 625 mcg | Units per Injection (mL): 37.5 units (0.375 mL)
Weeks 3–8
Daily Dose (mcg): 2500 mcg | Per-Injection Dose (mcg): 1250 mcg | Units per Injection (mL): 75 units (0.75 mL)
Long-term Storage Conditions
Lyophilized: βˆ’20 Β°C (βˆ’4 Β°F); reconstituted: 2–8 Β°C (35.6–46.4 Β°F).
Shipping Condition
Shipping conditions by inquiry

Peptide Vials (SLU-PP-332, 5 mg each): 8 weeks β‰ˆ 25 vials

12 weeks β‰ˆ 39 vials

16 weeks β‰ˆ 53 vials

Insulin Syringes (U-100): Per week: 14 syringes (2/day)

8 weeks: 112 syringes

12 weeks: 168 syringes

16 weeks: 224 syringes

Bacteriostatic Water (10 mL bottles): Use ~3.0 mL per vial for reconstitution. 8 weeks (25 vials): 75 mL β†’ 8 Γ— 10 mL bottles

12 weeks (39 vials): 117 mL β†’ 12 Γ— 10 mL bottles

16 weeks (53 vials): 159 mL β†’ 16 Γ— 10 mL bottles

Alcohol Swabs: One for the vial stopper + one for the injection site each administration. Per week: 28 swabs (4/day)

8 weeks: 224 swabs β†’ recommend 3 Γ— 100-count boxes

12 weeks: 336 swabs β†’ recommend 4 Γ— 100-count boxes

16 weeks: 448 swabs β†’ recommend 5 Γ— 100-count boxes

Product Gallery

Quick Inquiry

Customer Support & Price Inquiry

Send product, purity, quantity, destination and documentation requirements. Quantai will follow up through WhatsApp or email.

Email: kongq687@gmail.com

WhatsAppMia WhatsApp Business QR code

Address: Huangpu District, Guangzhou, China

Related Products

Related Services